FDA ousts chief spokesperson after agency inflated COVID 19 therapy gain
almost 4 years in Star Advertiser
The U.S. Food and Drug Administration has parted ways with its chief spokeswoman, according to a person with knowledge of the move, after the head of the agency exaggerated the benefits of an experimental therapy, and others in the Trump administration promoted the erroneous statements.
Who is popular today?
